Denmark has the third-largest commercial drug-development pipeline in Europe in absolute numbers and is second in Europe on the European Commission's Biotechnology Innovation Scoreboard. Investment in Danish biotechnology has reached more than EUR 3.8 billion — the second largest in Europe.
Denmark turns academic knowledge into successful business
With an export share of more than 90 percent of the total production, Denmark is among Europe’s largest exporters of medical technology products per capita.
Danish life science industry is an international example of how to successfully turn academic knowledge into commercial business. The industry consists of a dense network of universities, hospitals and companies working within medical technology, biotechnology and pharmaceuticals where focus is largely on research and development.
The Danish life science cluster is strong in R&D
Denmark is home to major pharmaceutical companies like Novo Nordisk, LeoPharma and Lundbeck as well as many biotechnology enterprises with a strong position in research and development.
Close collaboration between academia and business life
Denmark has a long tradition of close collaboration between basic research institutions, academic as well as commercial researchers and highly skilled companies. Add to this a focus on research and development, design and innovation, market testing, high-tech production and strong user-producer linkages, and you have the perfect base for your life science activities.